Complement Ther Med August 2021 PMID 34237387

Effects of chromium supplementation on blood pressure, body mass index, liver function enzymes and malondialdehyde in patients with type 2 diabetes: A systematic review and dose-response meta-analysis of randomized controlled trials.

Omid Asbaghi, Fatemeh Naeini, Damoon Ashtary-Larky, Mojtaba Kaviani, Mahnaz Rezaei Kelishadi, Elham Eslampour, Sajjad Moradi, Elahe Mirzadeh, Cain C T Clark, Amirmansour Alavi Naeini

Full text PDF Download social card

Mentions

Peak: 1 in Jul 2021

across 3 sources since Jul 2021

Extended reach

460

potential audience

Total likes

Video views

Mentions per month

Jul 2021 – Jun 2024

Where it's discussed

X / Twitter2 posts
News2 articles
YouTube1 videos

AI synopsis

What people are saying

The overall tone indicates agreement with the research's conclusion that chromium effectively reduces diastolic blood pressure and MDA levels in type 2 diabetes patients, as seen in comments like 'this could be a game-changer' and notes on doses of 200-1000 micrograms. There is an interest in how these findings might impact treatment, and discussions around the methodology show a moderate engagement level, highlighting the potential clinical relevance of the results.

AgreementModerate agreement

Most discussions acknowledge the study's findings that chromium lowers blood pressure and oxidative stress markers, reflecting general agreement on its outcomes.

InterestModerate interest

The interest level is moderate, with participants showing curiosity about the potential benefits and the specific doses involved, but not all express deep enthusiasm.

EngagementModerate engagement

Comments often reference the methodology and implications, with some contributors discussing dosage and the significance of the results, indicating a moderate level of engagement.

ImpactModerate impact

The responses suggest that the publication could influence future research or clinical considerations, especially around supplement dosage and effects on cardiovascular health.

Abstract in brief

The study reviewed 15 randomized controlled trials and found that chromium supplementation significantly lowered diastolic blood pressure (DBP) and malondialdehyde (MDA) levels in patients with type 2 diabetes, but it did not have a significant effect on body mass index (BMI), systolic blood pressure (SBP), or liver enzymes.
The research analyzed data from various sources up to November 2020, using a statistical model to determine the effects and assess variability between studies, ultimately suggesting that doses of 200-1000 micrograms per day of chromium may be effective.
The findings indicate that chromium may help reduce certain cardiovascular and oxidative stress indicators in type 2 diabetes, but it does not seem to influence BMI or liver enzyme activity based on current evidence.]

Read the full abstract

All mentions

Evaluating Chromium Supplementation in Managing Type 2 Diabetes

This video reviews a study of 15 randomized trials, showing that chromium supplementation lowers diastolic blood pressure and oxidative stress markers in type 2 diabetes patients, but has limited impact on BMI, systolic…

Ecoli podcast · Jun 30, 2024 2 views

Coventry Open Access

@CUPublications · X

Aug 11, 2021 · 1 like · 231 followers View post →

Nutr Reviews

@NutrReview · X

Jul 9, 2021 · 1 share · 226 followers View post →